Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AiLife Diagnostics is a clinical genomics company that provides advanced genetic testing services and bioinformatics solutions. Based in Houston, Texas, the company utilizes artificial intelligence and machine learning to improve the accuracy and efficiency of variant interpretation in Whole Exome and Whole Genome Sequencing. Their primary focus is on diagnosing rare Mendelian disorders and hereditary cardiovascular conditions, offering high-resolution insights to clinicians and researchers. AiLife Diagnostics integrates deep clinical expertise with proprietary computational algorithms to address the challenges of undiagnosed diseases. The company operates out of the Texas Medical Center, leveraging proximity to world-class medical institutions to advance precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AiLife Diagnostics.